Effect of 7-bromo-5-(2-pyridyl)-3H-1, 4-benzodiazepine-2(1H)-one, bromazepam (Ro 5-3350), a new minor tranquilizer, on psychoneurosis with special reference to the obsessive-compulsive symptoms.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D006998:Hypochondriasis / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced; D007046:Hysteria / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced
D001552:Benzazepines; D014149:Tranquilizing Agents